FOSAPREPITANT DIMEGLUMINE 150 mg/5mL (Fosaprepitant Dimeglumine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 150 mg/5mL

Fosaprepitant dimeglumine 150 mg/5mL is a lyophilized powder for intravenous solution, used to prevent nausea and vomiting. This medication is commonly administered in clinical settings for chemotherapy-induced nausea and vomiting (CINV).

Strength

150 mg/5mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9428-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant dimeglumine is primarily used to prevent nausea and vomiting caused by chemotherapy. It works by blocking substances in the body that can trigger these symptoms. This medication is often used in combination with other antiemetics to enhance its effectiveness. Patients undergoing chemotherapy may be prescribed fosaprepitant dimeglumine to manage CINV.

Side Effects

Common effects of fosaprepitant dimeglumine may include fatigue, headache, and diarrhea. Some patients may also experience constipation or dizziness. These effects are generally mild and temporary, but severe or persistent symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Fosaprepitant dimeglumine should be handled with care, following proper procedures for intravenous administration. It is important to use this medication exactly as prescribed and to inform healthcare providers of any allergies or medical conditions. Proper storage and handling are essential to maintain the medication's efficacy.

Avoid Interactions

Fosaprepitant dimeglumine may interact with other medications, including those metabolized by the liver's cytochrome P450 enzymes. It is important to inform healthcare providers of all medications being taken to avoid potential interactions. Alcohol and certain supplements may also affect the medication's effectiveness.

References

Frequently Asked Questions

Fosaprepitant dimeglumine is used to prevent nausea and vomiting, particularly in patients undergoing chemotherapy.

Fosaprepitant dimeglumine is administered intravenously as a solution prepared from a lyophilized powder.

Common side effects may include fatigue, headache, diarrhea, constipation, and dizziness.

Fosaprepitant dimeglumine may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Proper handling and administration procedures should be followed, and any allergies or medical conditions should be disclosed to healthcare providers.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.